Uganda on Saturday launched mpox vaccination campaign targeting high-risk populations in Kampala, the Ugandan capital, the cur ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Researchers at the University of Massachusetts Amherst have quantified the impacts of a constellation of social factors on ...

The blood center’s product testing lab verified the blood type and ensured it contained no viruses, such as HIV or West Nile.

Biotech giant Gilead Sciences, Inc. GILD has put up a strong performance amid a volatile market. Shares of this biotech giant ...

Intense global research is now exploring the clinical potential of CAR T-cell therapies beyond blood cancers, with therapies in development targeting solid tumours, autoimmune diseases, and infectious ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

HIV-1, like other viruses, lacks the machinery to produce its own proteins and must rely on the host cell to translate its genetic instructions. After entering host cells, it seizes control of the ...